Eating Aspirin Can Reduce Cancer Risk

& the proof is strong to encourage people over the age of 40 years ought to consume each day as a precaution.

Eating a low-dose aspirin can reduce the risk of plenty of types of cancer, scientists said on Tuesday (7 / 12).

But the findings are expected to trigger fierce debate has been going on about the benefits of taking aspirin, which increases the risk of bleeding in the stomach for of one,000 patients per year.

In a study of five trials involving 25,570 patients, researchers found that cancer deaths among those taking 75 milligrams aspiri doses per day is 21 percent lower in the work of the study & 34 percent lower after years.

Aspirin protects people from cancer of the stomach & intestines, the study found, with the number of cancer deaths amounted to 54 percent lower after years among those taking aspirin compared with those who do not.

Peter Rothwell from Oxfford University said despite taking aspirin causes a small risk of bleeding in the stomach, the risk that began "eliminated" by the benefits in reducing cancer risk & the risk of heart assault.

"Guide correctly historicallyin the past been warned that in healthy people in middle age, the small risk of bleeding on aspirin partially offset the benefits of prevention of stroke & heart assault," they said.

"But the reduction in deaths from some common cancers are now going to change this balance for plenty of people," Rothwell said, as quoted by Reuters Health & Science correspondent, Kate Kelland.

Aspirin, which was originally developed by Bayer, is an affordable drug that can be freely bought & used to relieve pain & reduce fever.

Various earlier studies have found that taking aspirin can reduce the risk of developing colon cancer or huge stomach & said the drug had such effects by blocking the enzyme cyclooxygenase2, which encourage inflammation & breakdown in tumor cells & is found at high levels.

The reduction in pancreatic cancer, stomach & brain death difficult to quantify due to a smaller amount.

In the Rothwell study, published in The Lancet, researchers found that the risk of death twenty years decreased by ten percent for patients with prostate cancer, 30 percent for patients with lung cancer, 40 percent for cancer of the stomach or intestine & 60 percent for patients oesophageal cancer in individuals who take aspirin.

Peter Elwood, an specialist on aspirin from Cardiff University Medical School who was not involved in the study, aspirin describes as "an fabulous drug."

But researchers are adding treatment with aspirin in the work of the experiment lasted only an average of between & two years, so its impact on the risk of cancer deaths may not represent results that may be achieved in a longer-term treatment.

"The risk of bleeding is very small compared with its benefits," they told reporters. "Yes, well, can not be denied is tragic if a person was taken to hospital & given a transfusion - because there is bleeding in his stomach - but compared to all that they would like to prevent, that is not how."